Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Severe combined immunodeficiency with sensitivity to ionizing radiation × amatuximab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 2 Severe combined immunodeficiency with sensitivity to ionizing radiation 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

amatuximab 1 Pemetrexed 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02357147 2020-03-17

ARTEMIS

Morphotek

Phase 2 Terminated

124 enrolled 10 charts

Other solid neoplasmThoracic

Severe combined immunodeficiency with sensitivity to ionizing radiation, Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡